Eloxx Pharmaceuticals, Inc.
OTC: ELOX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Other OTC
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Sumit Aggarwal
- Employees
- 18
- Headquarters
- Watertown, United States
- IPO year
- 1999
- Market cap
- $90.9M
- Website
- https://www.eloxxpharma.com
Loading ELOX…
Loading profile data…Frequently asked questions about ELOX
What does Eloxx Pharmaceuticals, Inc. (ELOX) do?
Eloxx Pharmaceuticals is a clinical-stage biopharmaceutical firm that specializes in developing therapeutic solutions through ribosome modulation. Its primary objective is to address rare and ultra-rare genetic diseases that arise from premature stop codons. The company's most advanced investigational compound, ELX-02, is currently progressing t...
Where does ELOX trade?
Eloxx Pharmaceuticals, Inc. (ELOX) trades on the Other OTC.
What sector is ELOX in?
Eloxx Pharmaceuticals, Inc. (ELOX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Eloxx Pharmaceuticals, Inc.?
Sumit Aggarwal is the chief executive officer of Eloxx Pharmaceuticals, Inc. (ELOX).
Where is Eloxx Pharmaceuticals, Inc. headquartered?
Eloxx Pharmaceuticals, Inc. is headquartered in United States.
Does ELOX pay a dividend?
Eloxx Pharmaceuticals, Inc. (ELOX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did ELOX go public?
Eloxx Pharmaceuticals, Inc. (ELOX) completed its initial public offering in 1999.